Author

Alexandra M. Dimesa

Observed name: Alexandra Dimesa

Institutions: Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

Observed institutions: University of North Florida, Mayo Clinic, Mayo Clinic in Florida, Mayo Clinic Comprehensive Cancer Center (Florida)

ORCID: 0009-0009-5600-8697

Observed ORCID: 0009-0009-5600-8697

OpenAlex ID: A5115728008

Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy

2024 · Alireza Shoari, Arghavan Ashja Ardalan, et al. · Biomolecules · 78

Matrix Metalloproteinases in Glioma: Drivers of Invasion and Therapeutic Targets

2025 · Ella E. Aitchison, Alexandra M. Dimesa, et al. · BioTech · 30

Directed evolution of metalloproteinase inhibitor TIMP-1 for selective inhibition of MMP-9 exploits catalytic and fibronectin domain interactions

2025 · Alireza Shoari, Mathew A. Coban, et al. · Journal of Biological Chemistry · 12

Matrix Metalloproteinases in Hepatocellular Carcinoma: Mechanistic Roles and Emerging Inhibitory Strategies for Therapeutic Intervention

2026 · Alexandra M. Dimesa, Mathew A. Coban, et al. · Cancers · 3

Abstract 2008 Engineered TIMP-1 Variants with Enhanced MMP-9 Specificity via Counter-Selection: Toward Improved Breast Cancer Therapy

2026 · Alireza Shoari, Alexandra Hockla, et al. · Journal of Biological Chemistry

Abstract LB233: Protein engineering of selective MMP-9 inhibitors reveals a therapeutic strategy for triple-negative breast cancer

2026 · Alireza Shoari, Alexandra Hockla, et al. · Cancer Research

Abstract 5115: Engineered TIMP-1 for selective MMP-9 inhibition: A novel strategy to suppress breast cancer invasiveness

2025 · Alireza Shoari, Alexandra Hockla, et al. · Cancer Research

Works count: 7

Citation count: 123

H-index: 3

I10-index: 3